Aldeyra Therapeutics, Inc. Contracts & Agreements

Master Services Agreement, effective as of August 15, 2024, between the Registrant and Danforth Global, Inc (Filed With SEC on November 7, 2024)

Separation and Consulting Letter Agreement, effective as of August 31, 2024, between the Registrant and Bruce Greenberg (Filed With SEC on November 7, 2024)

Fourth Amendment to Loan and Security Agreement, dated September 30, 2024, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the several banks and other financial... (Filed With SEC on October 2, 2024)

Third Amendment to Loan and Security Agreement, dated April 29, 2024, by and among the Registrant, Helio Vision, LLC, the several banks and other financial institutions or... (Filed With SEC on August 1, 2024)

Fifth Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of April 29, 2024 (Filed With SEC on August 1, 2024)

Open Market Sale AgreementSM by and between the Company and Jefferies LLC, dated August 1, 2024 (Filed With SEC on August 1, 2024)

Fourth Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of November 22, 2023 (Filed With SEC on March 7, 2024)

Aldeyra Therapeutics, Inc. 2023 Equity Incentive Plan, form of option agreement, and form of RSU agreement thereunder (Filed With SEC on August 3, 2023)

Second Amendment to Loan and Security Agreement, dated December 22, 2022 and effective as of December 31, 2022, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the... (Filed With SEC on December 27, 2022)

Offer Letter, effective as of October 21, 2015, between the Registrant and Stephen Machatha, Ph.D (Filed With SEC on March 17, 2022)

Offer Letter Amendment No. 1, effective as of January 1, 2018, between the Registrant and Stephen Machatha, Ph.D (Filed With SEC on March 17, 2022)

Offer Letter Amendment No. 2, effective as of March 23, 2021, between the Registrant and Stephen Machatha, Ph.D (Filed With SEC on March 17, 2022)

Third Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of August 12, 2021 (Filed With SEC on October 28, 2021)

Aldeyra Therapeutics, Inc. Amended and Restated Change in Control Plan (Filed With SEC on August 5, 2021)

Underwriting Agreement among Aldeyra Therapeutics, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters, dated April 28, 2021 (Filed With SEC on April 29, 2021)

First Amendment to Loan and Security Agreement, dated April 20, 2021, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the several banks and other financial... (Filed With SEC on April 21, 2021)

Underwriting Agreement among Aldeyra Therapeutics, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters, dated January 13, 2021 (Filed With SEC on January 14, 2021)

Second Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of October 7, 2020 (Filed With SEC on November 5, 2020)

Separation and Consulting Letter Agreement, effective as of March 9, 2020, between the Registrant and David Clark (Filed With SEC on May 7, 2020)

Amendment Number 1 and Waiver Agreement dated December 20, 2018 by and between Helio Vision, Inc. and the Massachusetts Eye and Ear Infirmary (Filed With SEC on March 12, 2020)

Exclusive License Agreement, effective as of July 7, 2016, between the Massachusetts Eye and Ear Infirmary and Helio Vision, Inc (Filed With SEC on March 12, 2020)

Description of Securities (Filed With SEC on March 12, 2020)

Loan and Security Agreement, dated as of March 25, 2019, by and among the Registrant, certain subsidiaries of the Registrant from time to time party thereto, the several banks and... (Filed With SEC on March 26, 2019)

Offer Letter, effective as of April 19, 2018, between the Registrant and David McMullin (Filed With SEC on March 8, 2019)

Agreement and Plan of Merger, dated as of January 24, 2019, by and among Aldeyra Therapeutics, Inc., Helio Vision, Inc., Halo Merger Sub, Inc., Halo Merger Sub, LLC and Josef von... (Filed With SEC on January 29, 2019)

Open Market Sale AgreementSM, dated December 28, 2018, by and between Aldeyra Therapeutics, Inc. and Jefferies LLC (Filed With SEC on December 28, 2018)

Offer Letter, effective as of July 30, 2018, between the Registrant and Joshua Reed (Filed With SEC on November 14, 2018)

Separation and Consulting Letter Agreement, effective as of July 27, 2018, between the Registrant and Stephen Tulipano (Filed With SEC on November 14, 2018)

Underwriting Agreement between Aldeyra Therapeutics, Inc. and Citigroup Global Markets Inc., as representative of the several underwriters, dated September 27, 2018 (Filed With SEC on September 28, 2018)

Amendment No. 2 to the Registrants 2013 Equity Incentive Plan (Filed With SEC on August 9, 2018)

First Amendment to Lease between WLC Three VI, L.L.C. and the Registrant, dated as of November 27, 2017 (Filed With SEC on March 29, 2018)

Lease Agreement by and between WLC Three VI, L.L.C. and the Registrant, dated as of September 11, 2017 (Filed With SEC on November 9, 2017)

Underwriting Agreement between Aldeyra Therapeutics, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters, dated September 19, 2017 (Filed With SEC on September 19, 2017)

ALDEYRA THERAPEUTICS, INC. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on June 2, 2017)

ALDEYRA THERAPEUTICS, INC. CHANGE IN CONTROL PLAN (Filed With SEC on March 30, 2017)

FIFTH AMENDMENT TOLOAN AND SECURITY AGREEMENT (Filed With SEC on March 30, 2017)

2,222,222 Shares ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 14, 2017)

AMENDMENT NO. 1 TO THE ALDEYRA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on August 10, 2016)

ALDEYRA THERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON MARCH 16, 2016) ALDEYRA THERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 10, 2016)

2,400,000 Shares ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 27, 2016)

ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON, MA 02421 December 15, 2015 (Filed With SEC on March 30, 2016)

SUBLEASE (Filed With SEC on March 30, 2016)

ALDEYRA THERAPEUTICS, INC. MANAGEMENT CASH INCENTIVE PLAN (AS ADOPTED EFFECTIVE MARCH 16, 2016) TABLE OF CONTENTS (Filed With SEC on March 18, 2016)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 13, 2015)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 14, 2015)

[Number of Shares] ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 5, 2015)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 20, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 22, 2015)

ALDEYRA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 22, 2015)

PURCHASE AGREEMENT (Filed With SEC on January 20, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 15, 2015)

ALDEYRA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 15, 2015)

PURCHASE AGREEMENT (Filed With SEC on January 13, 2015)

CONSENT TO SUBLEASE (Filed With SEC on November 12, 2014)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 12, 2014)

* * * * * (Filed With SEC on August 7, 2014)

UNDERWRITING AGREEMENT between ALDEYRATHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters ALDEYRA THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 7, 2014)

ALDEYRA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN NOTICE OF STOCK UNIT AWARD (Filed With SEC on March 17, 2014)

UNDERWRITING AGREEMENT between ALDEYRATHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters ALDEYRA THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on March 17, 2014)

Shares (Filed With SEC on March 17, 2014)

ALDEXA THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT December 20, 2012 TABLE OF CONTENTS (Filed With SEC on March 17, 2014)

Form of Representatives Warrant Agreement (Filed With SEC on March 17, 2014)

INDEMNITY AGREEMENT (Filed With SEC on March 17, 2014)

ALDEXA THERAPEUTICS, INC. February 19, 2014 (Filed With SEC on March 17, 2014)

ALDEYRA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN (AS ADOPTED ON SEPTEMBER 8, 2013) ALDEYRA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on March 17, 2014)

ALDEYRA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 17, 2014)

CONFIDENTIAL TREATMENT REQUESTED LICENSE AND SUPPLY AGREEMENT (Filed With SEC on January 27, 2014)

ALDEXA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN (AS ADOPTED ON SEPTEMBER 8, 2013) ALDEXA THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on January 27, 2014)

Shares (Filed With SEC on January 27, 2014)

AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on January 6, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2014)

NEURON SYSTEMS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2014)

CONFIDENTIAL TREATMENT REQUESTED LICENSE AND SUPPLY AGREEMENT (Filed With SEC on January 6, 2014)

NEURON SYSTEMS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN (as amended on September 8, 2013) (Filed With SEC on January 6, 2014)

NEURON SYSTEMS, INC. 2004 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (Filed With SEC on January 6, 2014)

INDEMNITY AGREEMENT (Filed With SEC on January 6, 2014)

ALDEXA THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT December 20, 2012 TABLE OF CONTENTS (Filed With SEC on January 6, 2014)

Category

Industry

Companies

Contracts

Aldeyra Therapeutics, Inc. Contracts & Agreements